SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 33 filers reported holding SINOVAC BIOTECH LTD in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $627,000 | -80.7% | 106,198 | -80.6% | 0.01% | -69.4% |
| Q2 2016 | $3,249,000 | +174.9% | 547,899 | +196.1% | 0.04% | +111.8% |
| Q1 2016 | $1,182,000 | -55.8% | 185,043 | -64.8% | 0.02% | -50.0% |
| Q3 2015 | $2,672,000 | -53.5% | 525,848 | -52.0% | 0.03% | -46.0% |
| Q2 2015 | $5,749,000 | +5.9% | 1,095,041 | 0.0% | 0.06% | -4.5% |
| Q1 2015 | $5,431,000 | -5.2% | 1,095,041 | 0.0% | 0.07% | -9.6% |
| Q4 2014 | $5,727,000 | +8.7% | 1,095,041 | 0.0% | 0.07% | +17.7% |
| Q3 2014 | $5,267,000 | +411.9% | 1,095,041 | +500.5% | 0.06% | +287.5% |
| Q2 2014 | $1,029,000 | +118.5% | 182,365 | +178.5% | 0.02% | +128.6% |
| Q1 2014 | $471,000 | -84.4% | 65,484 | -86.8% | 0.01% | -81.1% |
| Q4 2013 | $3,028,000 | -8.3% | 494,646 | -10.4% | 0.04% | +5.7% |
| Q3 2013 | $3,301,000 | -0.8% | 551,998 | -34.8% | 0.04% | -28.6% |
| Q2 2013 | $3,326,000 | – | 846,554 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,000,000 | 7.22% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.18% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.82% |
| Financial Gravity Asset Management, Inc. | 988 | $3,197,686 | 0.04% |
| Yorktown Management & Research Co Inc | 149,786 | $4,494 | 0.01% |
| Renaissance Technologies | 2,375,841 | $1,537 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,661 | $10,747 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $2,666 | 0.00% |